-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. annual/quarterly Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2010 to 2024.
- Cyclacel Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 12.6M shares, a 23.8% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 5.36M shares, a 529% increase from 2023.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 851K shares, a 92.4% decline from 2022.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.3M shares, a 26.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)